Caricamento...
Impact of HPV vaccination with Gardasil® in Switzerland
BACKGROUND: Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomaviruses (HPV), has been offered to 11–14 year-old schoolgirls in Switzerland since 2008. To evaluate its success and its potential impact on cervical cancer screening, HPV genotypes were ex...
Salvato in:
| Pubblicato in: | BMC Infect Dis |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741926/ https://ncbi.nlm.nih.gov/pubmed/29273004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2867-x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|